Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Published in: Clinical Research in Cardiology 7/2012

01-07-2012 | Letter to the Editors

Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension

Authors: Michele Correale, Deodata Montrone, Matteo Di Biase, Natale Daniele Brunetti

Published in: Clinical Research in Cardiology | Issue 7/2012

Login to get access

Excerpt

Sirs: …
Literature
1.
Anderson JR, Nawarskas JJ (2010) Pharmacotherapeutic management of pulmonary arterial hypertension. Cardiol Rev 18(3):148–162PubMedCrossRef
2.
Jansa P, Becvar R, Ambroz D, Palecek T, Tomcik M, Skacelova S, Aschermann M, Linhart (2011) A Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic. Clin Rheumatol (Epub ahead of print)
3.
Stringham R, Shah NR (2010) Pulmonary arterial hypertension: an update on diagnosis and treatment. Am Fam Phys 82(4):370–377
4.
Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon J, Steg PG, Tardif J-C, Tavazzi L, Tendera M, for the Heart Rate Working Group (2007) Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50:823–830PubMedCrossRef
5.
Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB et al (2006) Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27(1):65–75PubMedCrossRef
6.
Flannery G, Gehrig-Mills R, Billah B, Krum H (2008) Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers. Am J Cardiol 101(6):865–869PubMedCrossRef
7.
Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, SHIFT Investigators (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744):875–885PubMedCrossRef
8.
Werdan K, Ebelt H, Nuding S, Höpfner F, Hack G, Müller-Werdan U (2012) Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study. Clin Res Cardiol (Epub ahead of print)
9.
Nuding S, Ebelt H, Hoke RS, Krummenerl A, Wienke A, Müller-Werdan U, Werdan K (2011) Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine: MODI (f)Y trial. Clin Res Cardiol 100(10):915–923PubMedCrossRef
Metadata
Title
Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension
Authors
Michele Correale
Deodata Montrone
Matteo Di Biase
Natale Daniele Brunetti
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Clinical Research in Cardiology / Issue 7/2012
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-012-0437-1

Other articles of this Issue 7/2012

Clinical Research in Cardiology 7/2012 Go to the issue

Original Paper

Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study

Original Paper

Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease

Original Paper

The risk-to-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience

Letter to the Editors

A case of rotational atherectomy after implantation of the Medtronic CoreValve bioprosthesis

Original Paper

Longitudinal heterogeneity of coronary artery distensibility in plaques related to acute coronary syndrome

Original Paper

Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits